MCTC News Alert Microchannel Tech Cp (MCTC) 0.0050 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Microchannel Tech Cp (MCTC) 0.0050 $MCTC

BioLight Announces Issuance of U.S. Patent for the Long-Term Controlled-Release Drug-Delivery Insert Platform
PR Newswire - Wed Jul 02, 8:23AM CDT
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT) (OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the U.S. Patent and Trademark Office has issued patent number 8,765,166 covering the device that is inserted into the eye to treat an ocular condition that contains an active agent of a free acid salt form of a prostaglandin with a low elution rate profile that is contained in the long-term controlled-release insert platform. The patent will be in effect at least until May 2031. This patent covers the technology used in Eye-D®, the company's controlled-release latanoprost insert currently in a Phase 1/2a clinical study in the U.S. for the treatment of glaucoma.

BioLight Reports Successful Interim Results from Bladder Cancer Clinical Study
PR Newswire - Tue Jul 01, 4:23PM CDT
BioLight Life Sciences Investments Ltd. (OTC: BLGTY)(TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that Micromedic Technologies (TASE: MCTC), BioLight's cancer diagnostic cluster company, achieved successful interim results in a blinded bladder cancer clinical trial with its CellDetect® technology. As a result, Micromedic will continue the trial with the goal of developing a kit for monitoring the recurrence of bladder cancer. This study is being conducted at seven medical centers and is expected to be completed in the fourth quarter of 2014.

First Patient Enrolled in FDA Phase 1/2a Clinical Trial With BioLight's Controlled-Release Latanoprost Insert for the Treatment of Glaucoma
PR Newswire - Mon Jun 30, 8:00AM CDT
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT)(OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D®, the company's controlled-release latanoprost insert for the treatment of glaucoma.

BioLight Raises NIS 19 Million, Announces China Regulatory Approval for IOPtiMate(TM) for Glaucoma Surgery
PR Newswire - Thu Mar 06, 11:07AM CST
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT; OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the successful completion of an equity financing that raised gross proceeds of approximately NIS 19 million (USD 5.5 million).




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 167

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 251

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 174

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 234

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

Nevada King Gold Corp. Advances Phase 3 Drill Program

Updated Category News Views 64

Nevada King Gold Corp. Advances Phase 3 Drill Program Nevada King Gold Corp. (TSXV: NKG) (OTC: NKGFF), fondly referred to as Nevada King, is taking exciting steps forward as it embarks on its Phase III regional drill program. Recently, the company achieved a crucial milestone by receiving a Finding of No Significant Impact (FONSI) approval from the U.S. Bureau of Land...

Continue Reading
Understanding the Complexities of American Household Wealth Dynamics

Updated Category News Views 128

Reevaluating American Household Wealth A recent paper presented at the Mercatus Center sheds light on a critical topic: American household wealth might not be as substantial as it initially appears. The paper, titled “We Are Not as Wealthy as We Thought We Were,” articulates essential economic observations that may surprise many. The Illusion of Real Estate Wealth...

Continue Reading
Terran Orbital Corporation Investors May Have Class Action Rights

Updated Category News Views 94

Overview of the Allegations Against Terran Orbital Corporation Investors in Terran Orbital Corporation (NYSE: LLAP) may find themselves in a position to lead a class action lawsuit against the company. The firm of Rosen Law has announced the initiation of such a lawsuit for those who purchased shares between certain timestamps. The legal actions arise from claims of...

Continue Reading
Expanding Horizons: Town Square Dermatology's New Chapter

Updated Category News Views 135

Transformative Partnership in Dermatologic Care Epiphany Dermatology, renowned for its commitment to exceptional dermatologic services, has made significant strides by partnering with Town Square Dermatology. This collaboration enables Epiphany to enhance its reach in Iowa, affirming its mission of improving access to quality skin care. Celebrating the Legacy of Town...

Continue Reading
Hertz's Initiative to Encourage Voting with Free Day Rental

Updated Category News Views 71

Hertz Encourages Voter Participation with Free Rental Day As election day approaches, Hertz is stepping up to help citizens across the nation get to the polls with their exciting promotion called the Free Day on Election Day. This generous initiative offers customers one day free when reserving a rental car for at least two days, providing a crucial service during an...

Continue Reading